Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Tumor-derived KLK5 activates TMEM158+ cancer-associated fibroblasts to induce CD8+ T cell exhaustion and confer immunotherapy resistance in lung cancer.

AIM Immune checkpoint blockade (ICB) has improved the treatment landscape of lung squamous cell carcinoma (LUSC), but durable clinical benefit is limited by frequent therapeutic resistance. We aimed to define the microenvironmental mechanisms underlying ICB resistance in LUSC. METHODS Surgical specimens from LUSC pat...

Shuangpeng Pu, Guo-Dong Li, Yu-Ran Jiang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.